186 related articles for article (PubMed ID: 8689281)
1. Fate of human IgG from lupus erythematosus antinuclear antibody positive sera passively transfered to mice.
Herrera-Esparza R; Guzman-Enriquez L; Avalos-Diaz E
Rev Rhum Engl Ed; 1996 Feb; 63(2):111-8. PubMed ID: 8689281
[TBL] [Abstract][Full Text] [Related]
2. Transplacental transfer of human antinuclear antibodies in mice by injection of lupus IgG in pregnant animals.
Guzman-Enriquez L; Avalos-Diaz E; Herrera-Esparza R
J Rheumatol; 1990 Jan; 17(1):52-6. PubMed ID: 2313673
[TBL] [Abstract][Full Text] [Related]
3. Anti-La/SSB antibodies transported across the placenta bind apoptotic cells in fetal organs targeted in neonatal lupus.
Tran HB; Macardle PJ; Hiscock J; Cavill D; Bradley J; Buyon JP; Gordon TP
Arthritis Rheum; 2002 Jun; 46(6):1572-9. PubMed ID: 12115188
[TBL] [Abstract][Full Text] [Related]
4. Induction of systemic lupus erythematosus-like disease in mice by immunization with heparan sulfate.
Ofosu-Appiah W; Sfeir G; Viti D; Burashnikova E
Cell Immunol; 1998 Jan; 183(1):22-31. PubMed ID: 9578716
[TBL] [Abstract][Full Text] [Related]
5. Serum autoantibodies in systemic lupus erythematosus and correlation with cutaneous features.
Synkowski DR; Reichlin M; Provost TT
J Rheumatol; 1982; 9(3):380-5. PubMed ID: 6981704
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling of an anti-DNA autoantibody (V-88) and mapping of its V region epitopes recognized by heterologous and autoimmune antibodies.
Hobby P; Ward FJ; Denbury AN; Williams DG; Staines NA; Sutton BJ
J Immunol; 1998 Sep; 161(6):2944-52. PubMed ID: 9743357
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
[TBL] [Abstract][Full Text] [Related]
9. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
10. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O
Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
[TBL] [Abstract][Full Text] [Related]
11. Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.
Kumar S; Bunting KA; Kalsi J; Hinks JA; Latchman DS; Pearl LH; Isenberg DA
Immunology; 2005 Mar; 114(3):418-27. PubMed ID: 15720443
[TBL] [Abstract][Full Text] [Related]
12. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
13. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study of pristane-induced murine lupus model].
Cui GM; Liu G; Liu W; Kan B; Mao YQ; Wei YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):309-12. PubMed ID: 16608103
[TBL] [Abstract][Full Text] [Related]
15. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
16. Indirect immunofluorescence on HEp-2000 substrate is a sensitive method for detecting anti-Ro/SSA antibodies in patients with lupus erythematosus and/or photosensitivity.
Cozzani E; Drosera M; Siccardi M; Babbini G; Parodi A
J Rheumatol; 2008 Jul; 35(7):1320-2. PubMed ID: 18528967
[TBL] [Abstract][Full Text] [Related]
17. The significance of experimental models of systemic lupus erythematosus and antiphospholipid syndrome induced by idiotypic manipulation.
Shoenfeld Y
Isr J Med Sci; 1994 Jan; 30(1):10-8. PubMed ID: 8138385
[TBL] [Abstract][Full Text] [Related]
18. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
Guo H; Leung JC; Chan LY; Chan TM; Lai KN
Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
Faria AC; Barcellos KS; Andrade LE
J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
